The Upper-Echelon Perspective of Firm Competitive Behavior: Empirical Evidence from the U.S. Pharmaceutical Industry

How firms compete for an advantage is among the most critical questions in Business Strategy. While several researchers link executives to key strategic outcomes, much less is understood on how the Upper-Echelon team drives the actual competitive behavior of the firm, which is manifested in the lau...

Full description

Bibliographic Details
Main Author: Offstein, Evan Hayden
Other Authors: Management
Format: Others
Published: Virginia Tech 2014
Subjects:
Online Access:http://hdl.handle.net/10919/29850
http://scholar.lib.vt.edu/theses/available/etd-12012004-120754/
id ndltd-VTETD-oai-vtechworks.lib.vt.edu-10919-29850
record_format oai_dc
spelling ndltd-VTETD-oai-vtechworks.lib.vt.edu-10919-298502020-09-26T05:33:11Z The Upper-Echelon Perspective of Firm Competitive Behavior: Empirical Evidence from the U.S. Pharmaceutical Industry Offstein, Evan Hayden Management Arthur, Jeffrey B. Chen, Ming-Jer Carlson, Kevin D. Gnyawali, Devi R. Cobb, Anthony Terry Competitive behavior Governance Human Capital Chief Executive Officer (CEO) Executive compensation Top Management Team (TMT) Social Capital How firms compete for an advantage is among the most critical questions in Business Strategy. While several researchers link executives to key strategic outcomes, much less is understood on how the Upper-Echelon team drives the actual competitive behavior of the firm, which is manifested in the launching of observable and purposeful competitive actions within the marketplace. Considering that competitive behavior research tends to overlook the importance of human assets, in general, and executive human assets, in particular, I explore how the knowledge, skills, and abilities of the Chief Executive (CEO), Top Management Team (TMT), and Board of Directors (BOD) impact a firm's competitive behavior. In addition, I examine how sources of Social Capital, or the relationships between these Upper-Echelon actors, influence a firm's competitive behavior. Moreover, I argue and test for the moderating influence of executive compensation on firm competitive behavior. Applying relational demography to capture Human Capital and sources of Social Capital within the U.S. Pharmaceutical Industry, I find some empirical support that executives do, indeed, affect firm competitive behavior. Overall, the empirical evidence indicates that the Human Capital of the CEO, TMT, and BOD can influence all dimensions of a firm's Competitive Intensity. Unexpectedly and, contrary to prediction, executive dissimilarity (not similarity) tended to greatly influence a firm's Competitive Activity and Repertoire Complexity. Also, the moderating impact of executive bonus and incentive pay was largely supported. This dissertation contributes to both the competitive behavior and Upper-Echelon literatures. Notably, this dissertation adds to the very limited work that attempts to theoretically link and empirically test for executive impact on firm competitive behavior. By so doing, it begins to open the "black box" on how human assets at the Upper Echelon affect strategic outcomes through a firm's competitive behavior. Ph. D. 2014-03-14T20:19:33Z 2014-03-14T20:19:33Z 2004-11-17 2004-12-01 2007-12-02 2004-12-02 Dissertation etd-12012004-120754 http://hdl.handle.net/10919/29850 http://scholar.lib.vt.edu/theses/available/etd-12012004-120754/ offstein.pdf In Copyright http://rightsstatements.org/vocab/InC/1.0/ application/pdf Virginia Tech
collection NDLTD
format Others
sources NDLTD
topic Competitive behavior
Governance
Human Capital
Chief Executive Officer (CEO)
Executive compensation
Top Management Team (TMT)
Social Capital
spellingShingle Competitive behavior
Governance
Human Capital
Chief Executive Officer (CEO)
Executive compensation
Top Management Team (TMT)
Social Capital
Offstein, Evan Hayden
The Upper-Echelon Perspective of Firm Competitive Behavior: Empirical Evidence from the U.S. Pharmaceutical Industry
description How firms compete for an advantage is among the most critical questions in Business Strategy. While several researchers link executives to key strategic outcomes, much less is understood on how the Upper-Echelon team drives the actual competitive behavior of the firm, which is manifested in the launching of observable and purposeful competitive actions within the marketplace. Considering that competitive behavior research tends to overlook the importance of human assets, in general, and executive human assets, in particular, I explore how the knowledge, skills, and abilities of the Chief Executive (CEO), Top Management Team (TMT), and Board of Directors (BOD) impact a firm's competitive behavior. In addition, I examine how sources of Social Capital, or the relationships between these Upper-Echelon actors, influence a firm's competitive behavior. Moreover, I argue and test for the moderating influence of executive compensation on firm competitive behavior. Applying relational demography to capture Human Capital and sources of Social Capital within the U.S. Pharmaceutical Industry, I find some empirical support that executives do, indeed, affect firm competitive behavior. Overall, the empirical evidence indicates that the Human Capital of the CEO, TMT, and BOD can influence all dimensions of a firm's Competitive Intensity. Unexpectedly and, contrary to prediction, executive dissimilarity (not similarity) tended to greatly influence a firm's Competitive Activity and Repertoire Complexity. Also, the moderating impact of executive bonus and incentive pay was largely supported. This dissertation contributes to both the competitive behavior and Upper-Echelon literatures. Notably, this dissertation adds to the very limited work that attempts to theoretically link and empirically test for executive impact on firm competitive behavior. By so doing, it begins to open the "black box" on how human assets at the Upper Echelon affect strategic outcomes through a firm's competitive behavior. === Ph. D.
author2 Management
author_facet Management
Offstein, Evan Hayden
author Offstein, Evan Hayden
author_sort Offstein, Evan Hayden
title The Upper-Echelon Perspective of Firm Competitive Behavior: Empirical Evidence from the U.S. Pharmaceutical Industry
title_short The Upper-Echelon Perspective of Firm Competitive Behavior: Empirical Evidence from the U.S. Pharmaceutical Industry
title_full The Upper-Echelon Perspective of Firm Competitive Behavior: Empirical Evidence from the U.S. Pharmaceutical Industry
title_fullStr The Upper-Echelon Perspective of Firm Competitive Behavior: Empirical Evidence from the U.S. Pharmaceutical Industry
title_full_unstemmed The Upper-Echelon Perspective of Firm Competitive Behavior: Empirical Evidence from the U.S. Pharmaceutical Industry
title_sort upper-echelon perspective of firm competitive behavior: empirical evidence from the u.s. pharmaceutical industry
publisher Virginia Tech
publishDate 2014
url http://hdl.handle.net/10919/29850
http://scholar.lib.vt.edu/theses/available/etd-12012004-120754/
work_keys_str_mv AT offsteinevanhayden theupperechelonperspectiveoffirmcompetitivebehaviorempiricalevidencefromtheuspharmaceuticalindustry
AT offsteinevanhayden upperechelonperspectiveoffirmcompetitivebehaviorempiricalevidencefromtheuspharmaceuticalindustry
_version_ 1719341309195452416